8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 5, 2014

ALERE INC.

(Exact name of registrant as specified in charter)

Delaware	1-16789	04-3565120
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453

(Address of Principal Executive Offices) (Zip Code)

(781) 647-3900

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events.

On May 5, 2014, the Company issued a press release entitled “Alere Announces Separation of Chief Executive Officer and Chairman Roles and Review of Strategy,” a copy of which is filed with this Current Report on Form 8-K as Exhibit 99.1 and incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.	Description
99.1	Press Release dated May 5, 2014, entitled “Alere Announces Separation of Chief Executive Officer and Chairman Roles and Review of Strategy”

- 2 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ALERE INC.
Date: May 5, 2014	By:	/s/ Jay McNamara
		Jay McNamara
		Assistant Secretary

- 3 -

EXHIBIT INDEX

Exhibit No.	Description
99.1	Press Release dated May 5, 2014, entitled “Alere Announces Separation of Chief Executive Officer and Chairman Roles and Review of Strategy”

- 4 -

EX-99.1

Exhibit 99.1

ALERE ANNOUNCES SEPARATION OF CHIEF EXECUTIVE

OFFICER AND CHAIRMAN ROLES AND REVIEW OF STRATEGY

WALTHAM, Mass., May 5, 2014 – As part of its ongoing review and enhancement of its corporate governance policies, Alere Inc. (NYSE:ALR), a global leader in empowering individuals to take greater control of their health at home by connecting innovative diagnostics in the hands of patients to their healthcare providers, announces today that it has separated the roles of Chairman of the Board and Chief Executive Officer. The Board of Directors unanimously elected Gregg J. Powers as Chairman of the Board of Alere, while Ron Zwanziger will continue as President, Chief Executive Officer and a member of the Board of Directors.

Mr. Powers joined Alere’s Board of Directors in August 2013 and serves on the Board’s Nominating and Corporate Governance Committee. Mr. Powers also serves on the Board of Directors of Quantum Corporation (NYSE: QTM) and is the Chairman and Chief Executive Officer of Private Capital Management, an institutional investment management firm and significant Alere stockholder. In connection with the separation of the roles of Chairman and Chief Executive Officer, the duties of the Lead Independent Director will be assumed by Mr. Powers. John Levy, who has served as Alere’s Lead Independent Director since October 2013, will continue as a member of the Board of Directors and as Chair of the Audit Committee.

Alere also announces today that the Company is undertaking a comprehensive review of its strategy and operations to identify opportunities to enhance shareholder value. The Board intends to select and engage an international consulting organization to assist it with this process in the near future.

###

About Alere

By developing new capabilities in near-patient diagnosis, monitoring and health information technology, Alere enables individuals to take charge of improving their health and quality of life at home. Alere’s global leading products and services, as well as its new product development efforts, focus on infectious disease, toxicology, cardiology and diabetes. Alere is headquartered in Waltham, Massachusetts. For more information regarding Alere, please visit www.alere.com.

Media Contact

Jackie Lustig

Director, Corporate Communications

Jackie.Lustig@alere.com

781-314-4009